Concepedia

Ying‐Yi Li

YL

5

Publications

198

Citations

5

H-Index

2007

Active since

Affiliations

Kanazawa University(Current)

Shanghai Medical College of Fudan University

Fudan University Shanghai Cancer Center

University of Toyama

Ying‐Yi Li is an author at Kanazawa University specializing in drug development, tumor microenvironment, and natural sciences.

Top concepts

Publications per year

2007–2022

5

Publications

5

Proto‐oncogene, Pim‐3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad‐mediated apoptosis

Boryana Konstantinova Popivanova, Ying‐Yi Li, Hua‐chuan Zheng et al. · Cancer Science · 2007 · 114 citations · Full text

Essential contribution of Ets‐1 to constitutive Pim‐3 expression in human pancreatic cancer cells

Ying‐Yi Li, Yu Wu, Koichi Tsuneyama et al. · Cancer Science · 2008 · 37 citations · Full text

Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis‐inducing ability

Ying‐Yi Li, Yingying Wang, Tsuyoshi Taniguchi et al. · International Journal of Cancer · 2009 · 20 citations · Full text

Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity

Yingying Wang, Tsuyoshi Taniguchi, Tomohisa Baba et al. · Cancer Science · 2011 · 15 citations · Full text

, , +17

A single hepatitis B virus genome with a reporter allows the entire viral life cycle to be monitored in primary human hepatocytes

Ariunaa Sumiyadorj, Kazuhisa Murai, Tetsuro Shimakami et al. · Hepatology Communications · 2022 · 12 citations · Full text

Rows per page

1–5 of 5